XGN Market Cap History
Below is a table of the XGN market cap history going back to 11/2/2020:

Date XGN Market Cap
11/2/20201.39B
2/15/20211.55B
4/28/20211.26B
7/28/2021878.51M
10/26/2021658.38M
2/15/2022429.22M
4/26/2022192.74M
7/29/2022189.40M

Also see: XGN Shares Outstanding History
and XGN YTD Return
XGN Historical Market Cap:
-68.28% CAGR
XGN Historical Market Cap: +-68.28% CAGR

Mouse over chart for data details
11/2/20202/15/20214/28/20217/28/202110/26/20212/15/20224/26/20227/29/2022
Exagen is engaged in commercializing a portfolio of testing products under its AVISE® brand, several of which are based on its Cell-Bound Complement Activation Products (CB-CAPs) technology. CB-CAPs assess the activation of the complement system, a biological pathway that is implicated across various autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE). Co.'s main testing product, AVISE® CTD, enables diagnosis for patients presenting with symptoms indicative of a variety of connective tissue diseases (CTDs), and other related diseases with overlapping symptoms. AVISE® CTD utilizes Co.'s CB-CAPs technology to enable the diagnosis SLE. We show 8 historical shares outstanding datapoints in our XGN shares outstanding history coverage, used to compute XGN market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing XGN market cap history over the course of time is important for investors interested in comparing XGN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of XGN versus a peer is one thing; comparing XGN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like XGN can fluctuate over the course of history. With this page we aim to empower investors researching XGN by allowing them to research the XGN market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree XGN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Exagen (XGN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

XLRN Market Cap History
XNCR Market Cap History
XOMA Market Cap History
XON Market Cap History
XRAY Market Cap History
YMAB Market Cap History
YMTX Market Cap History
YTEN Market Cap History
ZBH Market Cap History
ZFGN Market Cap History
More Healthcare companies »

 

XGN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.